Zoetis Inc. (ZTS)
Data as of , from SEC Form 4 filings.
See up to 3 months of ZTS. The 7-day demo opens the 1M and 3M ranges and puts ZTS on your watchlist.
Start 7-day demoLatest ZTS insider trades
About Zoetis Inc. (ZTS)
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
- PARSIPPANY, NJ
- 14,500
- 2013
- XNYS
ZTS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 10 | 84,177 | |
| Option exercise | 2 | 1,598 | |
| Tax withholding / forfeiture | 1 | 274 | |
ZTS insider transactions (Form 4)
38130 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Grant or award | Phantom Stock Unit | 720.14 | $26.17 | $19K | ||
| Kevin Esch - Officer | Grant or award | Phantom Stock Unit | 360.07 | $26.17 | $9K | |
| Grant or award | Phantom Stock Unit | 277.77 | $26.17 | $7K | ||
| Grant or award | Phantom Stock Unit | 367.79 | $26.17 | $10K | ||
| Grant or award | Phantom Stock Unit | 303.49 | $26.17 | $8K | ||
| Astorga Jeannette Ferran - Officer | Grant or award | Phantom Stock Unit | 52.98 | $26.17 | $1K | |
| Grant or award | Phantom Stock Unit | 321.49 | $26.17 | $8K | ||
| Grant or award | Phantom Stock Unit | 367.79 | $26.17 | $10K | ||
| Option exercise | Common Stock | 799 | - footnote F1 | - | ||
| Tax withholding / forfeiture | Common Stock | 274 | $69.83 | $19K | ||
| Option exercise | Restricted Stock Unit | 799.07 | - footnote F1 | - | ||
| ||||||
| Mark Stetter - Director | Grant or award | Phantom Stock Unit | 342.37 footnote F3 | $73.02 | $25K | |
| ||||||
| James Saccaro - Officer | Grant or award | Restricted Stock Unit | 81,063 | $0.00 | - | |
| Frank A. Damelio - Director | Gift | Common Stock | 6,650 | $0.00 | - | |
| Grant or award | Phantom Stock Unit | 259.64 | $26.22 | $7K | ||
| Grant or award | Phantom Stock Unit | 616.09 | $26.22 | $16K | ||
| Grant or award | Phantom Stock Unit | 214.62 | $26.22 | $6K | ||
| Kevin Esch - Officer | Grant or award | Phantom Stock Unit | 308.05 | $26.22 | $8K | |
| Grant or award | Phantom Stock Unit | 237.64 | $26.22 | $6K | ||
| Grant or award | Phantom Stock Unit | 314.65 | $26.22 | $8K | ||
| Grant or award | Phantom Stock Unit | 314.65 | $26.22 | $8K | ||
| Astorga Jeannette Ferran - Officer | Grant or award | Phantom Stock Unit | 45.33 | $26.22 | $1K | |
| Grant or award | Phantom Stock Unit | 363.05 | $26.22 | $10K | ||
| Mark Stetter - Director | Grant or award | Phantom Stock Unit | 317.62 | $78.71 | $25K | |
| Michael B. McCallister - Director | Gift | Common Stock | 1,209 | $0.00 | - | |
| Mark Stetter - Director | Option exercise | Common Stock | 1,572 | - footnote F1 | - | |
| Mark Stetter - Director | Option exercise | Restricted Stock Unit | 1,572 | - footnote F1 | - | |
| ||||||
| Option exercise | Common Stock | 1,944 | - footnote F1 | - | ||
| Option exercise | Common Stock | 10,186 | - footnote F2 | - | ||
| Option exercise | Restricted Stock Unit | 1,944 | $0.00 | - | ||
| Option exercise | Deferred Stock Unit | 10,187 | $0.00 | - | ||
| ||||||
| Frank A. Damelio - Director | Open-market purchase | Common Stock | 6,650 | $75.39 footnote F1 | $501K | |
| ||||||
| Paul Bisaro - Director | Open-market purchase | Common Stock | 2,000 | $75.88 footnote F1 | $152K | |
| ||||||
| Michael B. McCallister - Director | Open-market purchase | Common Stock | 3,000 | $77.76 footnote F1 | $233K | |
| ||||||
| Kevin Esch - Officer | Tax withholding / forfeiture | Common Stock | 75 | $114.97 | $9K | |
| Kevin Esch - Officer | Option exercise | Common Stock | 259 | - footnote F1 | - | |
| Kevin Esch - Officer | Option exercise | Restricted Stock Unit | 259.92 | - footnote F1 | - | |
| ||||||
| Grant or award | Phantom Stock Unit | 550.64 | $39.64 | $22K | ||
Stock trades in ZTS disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Purchase |
ZTS insider trading FAQ
What is the latest insider trade for ZTS?
Zoetis Inc. (ZTS) had 12 insider filings in the last 90 days, with the most recent on 2026-10-14. The full record for ZTS runs to 130 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ZTS stock?
No insider purchases of ZTS were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling ZTS stock?
No insider sales of ZTS were filed in the last 90 days. 3 sales are on record for this company.
Where can I see ZTS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ZTS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kristin C. Peck view on EDGAR
- - Kevin Esch view on EDGAR
- - Rimma Driscoll view on EDGAR
- - Julie Fuller view on EDGAR
- - Keith Sarbaugh view on EDGAR
- - Astorga Jeannette Ferran view on EDGAR
- - Abhay U. Nayak view on EDGAR
- - Roxanne Lagano view on EDGAR
- - Julie Fuller view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ZTS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ZTS with a 7-day demo
- ZTS on your watchlist
- Every ZTS Form 4 filing on record
- Up to 3 months of ZTS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive